Indian Journal of Medical Biochemistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Related articles

VOLUME 28 , ISSUE 3 ( September-December, 2024 ) > List of Articles

ORIGINAL RESEARCH ARTICLE

Assessment of Effect of Magnesium Intake on Blood Pressure Control in Hypertensives: A Case-control Study with a Nested Intervention of Flax Seeds Administration to Increase Magnesium Intake

Vidhi Patel, Ashutosh Chauhan, Shubhangi Deshpande, Lalithambigai Arumugasamy, Nishi Patel

Keywords : Hypertension, Indian, Magnesium, Magnesium deficiency, Poor BP control, 24-hour urinary flaxseeds

Citation Information : Patel V, Chauhan A, Deshpande S, Arumugasamy L, Patel N. Assessment of Effect of Magnesium Intake on Blood Pressure Control in Hypertensives: A Case-control Study with a Nested Intervention of Flax Seeds Administration to Increase Magnesium Intake. Indian J Med Biochem 2024; 28 (3):55-59.

DOI: 10.5005/jp-journals-10054-0235

License: CC BY-NC 4.0

Published Online: 19-08-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aim and background: A significant proportion of hypertensive patients do not achieve good blood pressure (BP) control despite optimal medications and salt restriction. Considering the BP-lowering effect of magnesium reported in some previous studies, we wanted to assess the correlation between magnesium intake and control of BP in Indian hypertensives. Twenty-four-hour urinary magnesium excretion was used as a surrogate marker of magnesium intake. Further, the effect of supplementation of magnesium-rich flaxseeds on control of BP was assessed, in a subset of the study subjects. Methodology: In this case-control study, 40 patients of essential hypertension with poor BP control as per JNC-8 BP goals were enrolled as cases and 40 patients of essential hypertension with good BP control were enrolled as controls. Twenty-four-hour urinary samples were collected in both cases and controls and urinary magnesium-creatinine (Mg/Cr) ratios were estimated. The urinary Mg/Cr ratios of patients of the two groups were compared using the Mann–Whitney U test. A subset of 23 patients was given an intervention of three tablespoons of roasted whole flaxseeds daily for 4 weeks, and the significance of the change in mean BP, before and after the intervention, was assessed using a paired t-test. Results: The urinary Mg/Cr ratio in the good BP-control group [median = 77.05 [interquartile range (IQR)] = 23.51–101.80] was higher, compared to the poor BP-control group [median = 56.49 (IQR = 44.19–69.97)], with p-value = 0.02852, when tested with Mann–Whitney U test. In the subset of consenting participants, who took 3 Tbsp flax seeds daily, the average systolic BP and diastolic BP decreased significantly, from 141.13 (SD = 11) mm Hg and 87.65 (SD = 9.19) mm Hg to 134.22 (SD = 11.50) mm Hg and 84.65 (SD = 8.17) mm Hg, respectively (Paired t-test; p-value for SBP = 0.005, DBP = 0.013). Conclusion: Hypertensive patients with good BP control have higher levels of 24-hour urinary magnesium excretion when compared to patients with poor BP control. Flaxseeds can be used in hypertensive patients as an adjuvant to drug therapy to improve BP control. Clinical significance: Hypertensive patients can be advised to consume flax seeds regularly to maintain healthy magnesium levels and control hypertension.

PDF Share
  1. Goyal C, Andrabi SAS. Hypertension: The Silent Killer. Indian Council of Medical Research and Department of Health Research - Ministry of Health & Family Welfare, Government of India. New Delhi. 2018. Available from: https://www.icmr.nic.in/sites/default/files/press_realease_files/Hypertension.pdf.
  2. Challa HJ, Tadi P, Uppaluri KR. DASH diet (Dietary Approaches to Stop Hypertension). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482514/.
  3. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001;344:3–10. DOI: 10.1056/NEJM200101043440101.
  4. Banjanin N, Belojevic G. Changes of blood pressure and hemodynamic parameters after oral magnesium supplementation in patients with essential hypertension—An intervention study. Nutrients 2018;10(5):581. DOI: 10.3390/nu10050581.
  5. Vongpatanasin W, Peri-Okonny P, Velasco A, et al. Effects of potassium magnesium citrate supplementation on 24-hour ambulatory blood pressure and oxidative stress marker in prehypertensive and hypertensive subjects. Am J Cardiol 2016;118(6):849–853. DOI: 10.1016/j.amjcard.2016.06.041.
  6. Sanjuliani AF, Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol 1996;56(2):177–183. DOI: 10.1016/0167-5273(96)02716-7.
  7. Kostov K, Halacheva L. Role of magnesium deficiency in promoting atherosclerosis, endothelial dysfunction, and arterial stiffening as risk factors for hypertension. Int J Mol Sci 2018;19(6):1724. DOI: 10.3390/ijms19061724.
  8. Nielsen FH. Magnesium deficiency and increased inflammation: Current perspectives. J Inflamm Res 2018;2018(11):25–34. DOI: 10.2147/JIR.S136742.
  9. Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J Clin Res Ed 1983;286(6381):1847–1849. DOI: 10.1136/bmj. 286.6381.1847.
  10. Morán R, Mendía S, Gómez G, et al. Oral magnesium supplementation and metabolic Syndrome: A randomized double-blind placebo-controlled clinical trial. Adv Chronic Kidney Dis 2018;25(3):261–266. DOI: 10.1053/j.ackd.2018.02.011.
  11. Cunha AR, D'El-Rei J, Medeiros F, et al. Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women. J Hypertens 2017;35(1):89–97. DOI: 10.1097/HJH.00000000000 01129.
  12. Stitt FW, Clayton DG, Crawford MD, et al. Clinical and biochemical indicators of cardiovascular disease among men living in hard and soft water areas. Lancet 1973;1(7795):122–126. DOI: 10.1016/S0140-6736(73)90195-5.
  13. Durlach J, Bara M, Guiet-Bara A. Magnesium level in drinking water and cardiovascular risk factor: A hypothesis. Magnesium 1985;4(1): 5–15. PMID: 4033205.
  14. Banai S, Haggroth L, Epstein SE, et al. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res 1990;67(3):645–560. DOI: 10.1161/01.RES.67.3.645.
  15. Horie R, Gonzalez MD, Fernandez-Cruz A, et al. Comparative studies on the relation between nutritional conditions and blood pressure levels of two rural populations with lower incidences of ischemic heart diseases in Japan and Spain. J Cardiovasc Pharmacol 1990;16(Suppl 8):S38–S39. PMID: 1706028.
  16. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis risk in communities study. J Clin Epidemiol 1995;48(7):927–940. DOI: 10.1016/0895-4356(94)00200-A.
  17. Song Y, Manson JE, Cook NR, et al. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 2005;96(8):1135–1141. DOI: 10.1016/j.amjcard.2005.06.045.
  18. Schwalfenberg GK, Genuis SJ. The importance of magnesium in clinical healthcare. Scientifica (Cairo) 2017:2017:4179326. DOI: 10.1155%2F2017%2F417932.
  19. Flink EB. Magnesium deficiency. W V Med J 1990;86(10):459–463. PMID: 2238630.
  20. Wang JL, Shaw NS, Yeh HY, et al. Magnesium status and association with diabetes in the Taiwanese elderly. Asia Pac J Clin Nutr 2005;14(3):263–269. PMID: 16169838.
  21. Mejía-Rodríguez F, Shamah-Levy T, Villalpando S, et al. Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex 2013;55:275–284. DOI: 10.21149/spm.v55i3.7210.
  22. Hewitt D, Neri LC. Development of the ‘Water Story’: Some recent Canadian studies. J Environ Pathol Toxicol 1980;4(2–3):51–63. PMID: 7007563.
  23. Chidambaram N, Sethupathy S, Saravanan N, et al. Relationship of sodium and magnesium intakes to hypertension proven by 24-hour urinalysis in a South Indian population. J Clin Hypertens (Greenwich) 2014;16(8):581–586. DOI: 10.1111/jch.12361.
  24. Yamori Y, Sagara M, Mizushima S, et al. An inverse association between magnesium in 24-h urine and cardiovascular risk factors in middle-aged subjects in 50 CARDIAC Study populations. Hypertension Research 2015;38:219–225. DOI: 10.1038/hr.2014.158.
  25. Page MR. The JNC 8 hypertension guidelines: An in-depth guide. Am J Manag Care 2014;20(1 Spec No.):E8. PMID: 25618230.
  26. Seo JW, Park TJ. Magnesium metabolism. Electrolyte Blood Press 2008;6(2):86–95. DOI: 10.5049/EBP.2008.6.2.86.
  27. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003;24(2):47–66. PMID: 18568054.
  28. Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 2011;13(11):843–847. DOI: 10.1111/j.1751-7176.2011.00538.x.
  29. Patni N, Fatima M, Lamis A, et al. Magnesium and hypertension: Decoding novel anti-hypertensives. Cureus 2022;14(6):e25839. DOI: 10.7759/cureus.25839.
  30. Colussi NA, Todaro JS, Rodríguez JP, et al. Dietary supplementation with integral chia and flax flours ameliorates systemic inflammation. Medicina (B Aires) 2024;84(2):206–220. PMID: 38683505.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.